US Stock MarketDetailed Quotes
ABVX Abivax S.A.
- 7.650
- -0.110-1.42%
Close Dec 20 16:00 ET
- 7.650
- 0.0000.00%
Post 16:12 ET
481.35MMarket Cap-2.15P/E (TTM)
7.830High7.390Low258.03KVolume7.570Open7.760Pre Close1.97MTurnover0.87%Turnover RatioLossP/E (Static)62.92MShares17.02052wk High2.37P/B226.66MFloat Cap7.11052wk Low--Dividend TTM29.63MShs Float17.020Historical High--Div YieldTTM5.67%Amplitude7.110Historical Low7.618Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Abivax S.A. Stock Forum
Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
Abivax has announced initial preclinical combination data of obefazimod and etrasimod in an inflammatory bowel disease (IBD) mouse model. The company is conducting studies with multiple oral and injectable therapies, with additional data expected in Q4 2024. The p...
No comment yet